Clinical Trials on Retroviridae Infections

Total 56503 results

University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia

HIV Infection

Zambia
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

HIV Infection

United States
Barbara Ensoli, MD
Novartis Vaccines

Terminated

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

HIV Infection

Italy
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (BRYOLAT)

HIV Infection

Spain
University of Wisconsin, Madison

Withdrawn

Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring (RELATES)

HIV Infection
University of Washington
National Institutes of Health (NIH); Fogarty International Center of the National... and other collaborators

Completed

Text Messaging to Improve HIV Testing Among Young Women in Kenya (T2T)

HIV Infection

Kenya
ViiV Healthcare

Completed

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

HIV Infection

United States
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (RAL-PEP)

HIV Infection

Spain
University of California, San Francisco
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; Ibis... and other collaborators

Withdrawn

Effectiveness of the Diaphragm for HIV Prevention

HIV Infection

South Africa, Zimbabwe
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
Family AIDS Caring Trust
World Health Organization; Canadian International Development Agency

Unknown

Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe (EPAZ)

HIV Infection

Zimbabwe
ApoPharma

Completed

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

HIV Infection

South Africa
Tibotec Pharmaceuticals, Ireland

Completed

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

HIV Infection

United States, Australia, France, United Kingdom, Germany, Spain, Belgium, Portugal, Canada, Argentina, Brazil, Austria, Hungary
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
Medecins Sans Frontieres, Netherlands

Completed

Comparison of HIV Testing Algorithms

HIV Infection

Ethiopia
Columbia University
National Institute of Mental Health (NIMH)

Completed

Using Multimedia Technologies to Disseminate an HIV Prevention

HIV Infection

United States
Hospitales Universitarios Virgen del Rocío

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (MonDar)

HIV-infection

Spain
Pfizer
Altmarc Inc.

Completed

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

HIV Infection
International AIDS Vaccine Initiative
University of Rochester; Aaron Diamond AIDS Research Center

Completed

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults (C001)

HIV Infection

United States
Genetic Immunity
IRCCS Policlinico S. Matteo; ViroStatics srl

Completed

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC) (PHPC-02)

HIV Infection

Italy
Centre For International Health
Makerere University

Completed

Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda (InvolvMaleUg)

HIV Infection

Uganda
University of British Columbia
National Institute on Drug Abuse (NIDA)

Completed

Use of Incentives to Engage Drug Users in HIV Therapy (Incentives-1)

HIV Infection

Canada
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Kenya, Malawi
St Stephens Aids Trust

Completed

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (SSAT033)

HIV Infection

United Kingdom
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study) (SILCAAT)

HIV Infection

United States
Avexa

Completed

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

HIV Infection

Australia
VIRxSYS Corporation

Active, not recruiting

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

HIV Infection

United States
GlaxoSmithKline

Terminated

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

HIV Infection

United States, Belgium
Istituto Superiore di Sanità

Completed

Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT (ISS OBS T-001)

HIV Infection

Italy
French National Agency for Research on AIDS and...

Completed

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study (EP 44)

HIV Infection

France
Georgetown University
Advanced Biotherapy, Inc.

Completed

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

HIV Infection

United States
University of Oklahoma
Abbott

Terminated

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

HIV Infection

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Of EPZICOM Tablet

HIV Infection

Japan
Abbott

Completed

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients (MONARK)

HIV Infection
Arribas, Jose R., M.D.
Abbott; Pulido, Federico, M.D.

Completed

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

HIV Infection

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Intermittent Versus Continuous Medication in the Treatment of HIV

HIV Infection

United States
French National Agency for Research on AIDS and...

Completed

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

HIV Infection

Vietnam
University of Chile
ViiV Healthcare

Unknown

Proviral DNA as a Target for HIV-1 Resistance Analysis (HIV)

HIV Infections | HIV/AIDS | HIV Seropositivity | Viral Infection

Chile
University Hospital, Strasbourg, France

Unknown

First Event of Infection by HIV-1 of Uterine Vaginal Tissue

HIV Infection of the Uterine Vaginal Tissues

France
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Completed

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (VALIDATE)

HIV Infections | HIV Infection | Herpes Simplex Type II

Canada, United Kingdom, Argentina, Brazil
National Institute of Allergy and Infectious Diseases...
Medstar Health Research Institute

Recruiting

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

HIV | Infectious Diseases | Immunodeficiencies

United States
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); AIDS Clinical... and other collaborators

Recruiting

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study

HIV Infection

Malawi, Botswana, South Africa, Zimbabwe
HIV Prevention Trials Network

Completed

Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection

Acute HIV Infection

Malawi
ANRS, Emerging Infectious Diseases

Completed

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire (PRECO-CI)

HIV Infection

Côte D'Ivoire
Radboud University Medical Center

Completed

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients (PRADA)

HIV Infections | HIV Infection

Germany, Netherlands
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

HIV Infection

United States, Puerto Rico
AbbVie (prior sponsor, Abbott)

Completed

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Human Immunodeficiency Virus Infection
ViiV Healthcare
GlaxoSmithKline

Terminated

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET) (SIGNET)

Infection, Human Immunodeficiency Virus

Spain, France, Germany
ViiV Healthcare
GlaxoSmithKline

Completed

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Infection, Human Immunodeficiency Virus I

United States, Spain, Canada, Russian Federation, Romania, Belgium, South Africa
National Institute on Drug Abuse (NIDA)

Completed

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals (MAP)

HIV Infections | HIV Infection

United States

Clinical Trials on Retroviridae Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations